iOnctura announces EUR80 million Series B financing to progress pipeline through Phase II trials
07.08.2025 - 18:03:52
Led by new investor Syncona, with participation from the European Innovation Council Fund as well as existing investorsTo progress pipeline of innovative, first-in-class, oral cancer treatments targeting neglected and hard-to-treat cancersTo accelerate development of lead asset roginolisib for treatment of uveal melanoma and a number of other oncology indicationsView original content:https://www.prnewswire.co.uk/news-releases/ionctura-announces-eur80-million-series-b-financing-to-progress-pipeline-through-phase-ii-trials-302176882.html
